HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yukitoshi Takahashi Selected Research

Inflammation (Inflammations)

12/2018Influence of Inflammation on the Pharmacokinetics of Perampanel.
8/2015Reduction of interleukin-10 production by B cells in intractable toxic epidermal necrolysis.
7/2015Semi-quantitative analyses of antibodies to N-methyl-d-aspartate type glutamate receptor subunits (GluN2B & GluN1) in the clinical course of Rasmussen syndrome.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yukitoshi Takahashi Research Topics

Disease

46Encephalitis (Encephalitis, Rasmussen)
01/2023 - 08/2003
43Epilepsy (Aura)
03/2024 - 03/2003
41Seizures (Absence Seizure)
05/2022 - 03/2003
31Limbic Encephalitis (Paraneoplastic Limbic Encephalitis)
01/2021 - 09/2005
13Tuberous Sclerosis (Bourneville's Disease)
01/2021 - 01/2017
12Stevens-Johnson Syndrome (Lyell's Syndrome)
01/2020 - 11/2008
10Brain Diseases (Brain Disorder)
03/2024 - 10/2005
9Myoclonic Epilepsies (Myoclonic Encephalopathy)
01/2020 - 01/2008
9Drug Resistant Epilepsy
01/2020 - 06/2003
8Neoplasms (Cancer)
04/2024 - 01/2007
8Leukocytosis (Pleocytosis)
02/2023 - 10/2007
7Partial Epilepsies (Epilepsy, Partial)
03/2024 - 07/2011
7Anti-N-Methyl-D-Aspartate Receptor Encephalitis
01/2021 - 01/2010
6Autoimmune Diseases of the Nervous System
04/2024 - 07/2007
6Spasm (Spasms)
01/2022 - 07/2011
6Hyperammonemia
12/2019 - 09/2012
6Ovarian Teratoma
05/2017 - 01/2007
6Infections
08/2015 - 01/2004
6Status Epilepticus (Complex Partial Status Epilepticus)
07/2015 - 06/2003
6Disease Progression
07/2015 - 09/2005
6Cerebellar Ataxia (Dysmetria)
10/2013 - 06/2003
5Infantile Spasms (West Syndrome)
01/2022 - 05/2012
5Body Weight (Weight, Body)
01/2022 - 04/2015
5Epilepsia Partialis Continua
09/2011 - 08/2003
4Nervous System Diseases (Neurological Disorders)
01/2023 - 11/2013
4Temporal Lobe Epilepsy
01/2023 - 06/2007
4Angiomyolipoma
01/2020 - 01/2017
4Astrocytoma (Pilocytic Astrocytoma)
01/2019 - 01/2017
4Drug-Related Side Effects and Adverse Reactions
01/2018 - 02/2010
4Ataxia (Dyssynergia)
03/2017 - 05/2007
4Creutzfeldt-Jakob Syndrome (Creutzfeldt-Jakob Disease)
04/2014 - 10/2012
3Cognitive Dysfunction
01/2023 - 09/2014
3Demyelinating Diseases (Demyelinating Disease)
05/2022 - 11/2014
3Myoclonus (Nocturnal Myoclonus)
10/2020 - 07/2007
3Inflammation (Inflammations)
12/2018 - 07/2015
3Teratoma (Teratoid Tumor)
05/2017 - 01/2010
3Virus Diseases (Viral Diseases)
03/2016 - 03/2011
3Relapsing Polychondritis
01/2015 - 12/2009
3Meningoencephalitis
01/2014 - 01/2008
2Hyponatremia
08/2023 - 12/2019
2Down Syndrome (Down's Syndrome)
01/2023 - 01/2016
2Focal cortical dysplasia of Taylor
01/2022 - 07/2021

Drug/Important Bio-Agent (IBA)

60Glutamate Receptors (Glutamate Receptor)IBA
05/2023 - 06/2003
54AntibodiesIBA
03/2024 - 06/2003
37AutoantibodiesIBA
02/2023 - 01/2005
20Anticonvulsants (Antiepileptic Drugs)IBA
07/2021 - 11/2006
18N-Methylaspartate (NMDA)IBA
02/2023 - 01/2005
17Phenytoin (Dilantin)FDA LinkGeneric
08/2023 - 01/2011
17Carbamazepine (Tegretol)FDA LinkGeneric
08/2023 - 08/2005
15N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2023 - 07/2008
14Valproic Acid (Depakote)FDA LinkGeneric
08/2023 - 06/2003
14trans-sodium crocetinate (crocetin)IBA
01/2021 - 01/2017
13Phenobarbital (Luminal)FDA Link
08/2023 - 06/2003
13SteroidsIBA
01/2021 - 01/2004
11CytokinesIBA
10/2015 - 10/2008
10NR2B NMDA receptorIBA
08/2010 - 08/2003
9MethylprednisoloneFDA LinkGeneric
01/2021 - 05/2007
8perampanelIBA
03/2024 - 01/2017
8Lamotrigine (Lamictal)FDA LinkGeneric
01/2022 - 09/2011
8Clobazam (HR 376)IBA
01/2020 - 06/2005
7EpitopesIBA
09/2014 - 01/2005
6Topiramate (Topamax)FDA LinkGeneric
01/2018 - 07/2010
6Intravenous Immunoglobulins (IVIG)FDA Link
02/2017 - 01/2004
6Proteins (Proteins, Gene)FDA Link
01/2014 - 07/2008
5AmmoniaIBA
12/2015 - 09/2012
5Glutamic Acid (Glutamate)FDA Link
12/2015 - 03/2011
5Immunoglobulin G (IgG)IBA
04/2013 - 05/2007
4Adrenal Cortex Hormones (Corticosteroids)IBA
04/2024 - 09/2014
4Biomarkers (Surrogate Marker)IBA
03/2024 - 11/2013
4Zonisamide (Zonegran)FDA LinkGeneric
08/2023 - 08/2005
4Adrenocorticotropic Hormone (ACTH)FDA Link
01/2022 - 07/2013
4stiripentolIBA
01/2020 - 11/2009
4Cytochrome P-450 CYP2C19IBA
01/2020 - 01/2011
4EnzymesIBA
12/2018 - 01/2012
4Prednisolone (Predate)FDA LinkGeneric
02/2017 - 02/2008
4Immunoglobulins (Immunoglobulin)IBA
07/2016 - 06/2005
4ChemokinesIBA
10/2015 - 11/2014
4HLA-B Antigens (HLA-B)IBA
04/2014 - 11/2008
4erucylphosphocholineIBA
09/2011 - 01/2005
3SodiumIBA
08/2023 - 02/2019
3Antipsychotic Agents (Antipsychotics)IBA
08/2023 - 11/2016
3BenzodiazepinesIBA
08/2023 - 08/2015
3Granzymes (Granzyme)IBA
02/2023 - 03/2008
3Uridine Diphosphate (UDP)IBA
03/2017 - 06/2014
3Tacrolimus (Prograf)FDA LinkGeneric
09/2016 - 11/2007
3Cytochrome P-450 CYP2C9IBA
04/2015 - 01/2011
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
11/2013 - 10/2008
3DNA (Deoxyribonucleic Acid)IBA
01/2012 - 10/2007
3Immunoglobulin M (IgM)IBA
08/2009 - 09/2005
3glutamate receptor delta 2IBA
02/2008 - 09/2005
3barbituric acid (barbiturate)IBA
10/2007 - 06/2003
3Ionotropic Glutamate ReceptorsIBA
10/2007 - 09/2005
2Cytochrome P-450 CYP3AIBA
03/2024 - 01/2018
2Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2023 - 11/2014
2rufinamideFDA Link
01/2022 - 01/2017

Therapy/Procedure

52Therapeutics
04/2024 - 03/2003
6Immunotherapy
02/2023 - 07/2010
3Ketogenic Diet
03/2018 - 07/2011
3Aftercare (After-Treatment)
05/2017 - 09/2013
3Artificial Respiration (Mechanical Ventilation)
01/2011 - 10/2005